Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY
Holding ALNY?
Track your performance easily
See the Price Targets and Ratings of:
ALNY Analyst Ratings
Strong Buy
18 Buy
6 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ALNY Stock 12 Month Forecast
Average Price Target
$312.62
▲(12.68% Upside)
| Highest Price Target$400.00 | Average Price Target$312.62 | Lowest Price Target$180.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
Reiterated
11/04/24
TD Cowen
Assigned
11/01/24
Evercore ISI
Assigned
11/01/24
Barclays
Reiterated
11/01/24
Oppenheimer
Reiterated
11/01/24
Morgan Stanley
Reiterated
11/01/24
Scotiabank
Reiterated
11/01/24
Raymond James
Reiterated
11/01/24
Needham
Reiterated
10/31/24
Canaccord Genuity
Reiterated
10/31/24
Wells Fargo
$275
Hold
-0.88%
Downside
Assigned
10/31/24
Alnylam Pharma (ALNY) Receives a Hold from Wells Fargo
Chardan Capital
$300
Buy
8.14%
Upside
Reiterated
10/31/24
Alnylam Pharma: Strategic Growth and Market Dominance Potential
Bank of America Securities
$314→$315
Buy
13.54%
Upside
Reiterated
10/31/24
Alnylam Pharmaceuticals: Strong Product Performance and Strategic Positioning Underpin Buy Rating
BMO Capital
$300
Buy
8.14%
Upside
Reiterated
10/31/24
Analysts' Top Healthcare Picks: C4 Therapeutics (CCCC), Alnylam Pharma (ALNY)
Leerink Partners
$180
Hold
-35.12%
Downside
Reiterated
10/31/24
Analysts Have Conflicting Sentiments on These Healthcare Companies: Equillium (NASDAQ: EQ), Quest Diagnostics (NYSE: DGX) and Alnylam Pharma (NASDAQ: ALNY)
Best Analysts Covering Alnylam Pharma
Which Analyst Should I Follow If I Want to Buy ALNY and Sell After:
1 Month
xxx
Success Rate
12/22 ratings generated profit
Average Return
+0.46%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 54.55% of your transactions generating a profit, with an average return of +0.46% per trade.
3 Months
xxx
Success Rate
20/31 ratings generated profit
Average Return
+5.61%
assigned a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 64.52% of your transactions generating a profit, with an average return of +5.61% per trade.
1 Year
Success Rate
18/22 ratings generated profit
Average Return
+24.29%
reiterated a buy rating 2 months ago
Copying Paul Matteis's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +24.29% per trade.
2 Years
xxx
Success Rate
22/23 ratings generated profit
Average Return
+39.71%
assigned a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 95.65% of your transactions generating a profit, with an average return of +39.71% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ALNY Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
6
5
2
2
1
Buy
18
36
37
60
46
Hold
11
15
12
16
10
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
35
56
51
78
57
Each month's total comprises the sum of three months' worth of ratings.
ALNY Financial Forecast
ALNY Stock Forecast FAQ
What is ALNY’s average 12-month price target, according to analysts?
Based on analyst ratings, Alnylam Pharmaceuticals’s 12-month average price target is $312.62.
What is ALNY’s upside potential, based on the analysts’ average price target?
Alnylam Pharmaceuticals has 12.68% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ALNY a Buy, Sell or Hold?
Alnylam Pharmaceuticals has a consensus rating of Strong Buy which is based on 18 buy ratings, 6 hold ratings and 0 sell ratings.
What is Alnylam Pharmaceuticals’s price target?
The average price target for Alnylam Pharmaceuticals is $312.62. This is based on 24 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $400.00 ,the lowest forecast is $180.00. The average price target represents 12.68% Increase from the current price of $277.43.
The highest analyst price target is $400.00 ,the lowest forecast is $180.00. The average price target represents 12.68% Increase from the current price of $277.43.
What do analysts say about Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 24 Wall Streets Analysts.
How can I buy shares of ALNY?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.